International Conference on Parkinsons and Neurodegenerative diseases: PARKINSONS 2019

About Conference

Conference Series LLC LTD proudly presents International Conference on Parkinson’s and Neurodegenerative diseases. We invite participants around the world to Dubai, UAE for Parkinson's 2019 held during December 02-03, 2019.

Parkinson's deals with Neurological Syndromes caused due to leakage of electric impulse in neurons which leads to loss of communication. This kind of medical conditions are getting frequent in humans at present situations. It has been observed there are number of diseases associated with Neurological disorders for examples Parkinson’s diseases, Huntington’s, Alzheimer’s disease, brain tumours, Multiple Sclerosis, Spinal Muscular Atrophy, Brain Stroke, Epilepsy, Amyotrophic Lateral Sclerosis.

According to current survey Neurological disorders occupy first place in Europe Brain disorders are like Brain Tumour, Cerebral palsy, chiari malformation, Craniofacial abnormalities, Craniosynostosis, Developmental disorders, Encephalopathy, Epilepsy are recognized by World Health Organization in Europe. It is been identified 1.2 million people in Europe are suffering with Parkinson’s approximately 260000 people in Germany, 200000 people in Italy, 150000 people in Spain, 120000 people in UK, 117000 people in France are suffering from Parkinson's disease.

World Health Organization (WHO) and World Federation of Neurology (WFN) were collaborated after find the rate of Neurological disorders worldwide. An international Survey of Country Resources for Neurological disorders effects 109 countries and covering over 90% of the world’s population. This survey helps to collect valuable information regarding aspects of neurological care all around the world.

At National Institute of Health funding package is of $34 billion for the economic year 2017 to improve life of patients who are suffering from Parkinson’s disease and to raise the awareness on Neurological disorders around the World. PRP (Parkinson's Research Program) fund received amount of $16 million annually to research in neuromuscular disorders such as Alzheimer’s, Parkinson’s disease & Huntington’s disease.

Why to attend?

International Conference on Parkinson’s and Neurodegenerative diseases provides best plat form for Neurologists, Neurosurgeons, Scientists, Clinical Industry Specialists, Neurology Experts, Young Researchers with an aim to make patients feel better with innovative research outcomes.

Target audience:

Neuro physicians, Neruo surgeons, Neurologists, Psychiatrist, Physiotherapists, Neruo Specialists, Researchers, Professors, Industrials Experts, Nutritional Scientists, Lecturers and Students from Academic study in Parkinson’s and Huntington’s diseases , Pharma researchers on Neurology and Neuroscience, Therapists and Diagnostic Experts.

Market Analysis

On behalf of our Organizing committee members we welcome attendees like Speakers, Exhibitors, delegates, Poster presenters, Students, Young researchers from across the world to unleash the innovative ideas in the field of neuroscience and brain disorders at Parkinson’s congress 2019 held during 29-31, August 2019

This Parkinson's International conference of Europe focus on innovative ideas of Parkinson’s and Huntington’s diseases treatment and research

Reasons to undertake:

Parkinson's congress receive great response and support from worldwide NeuroResearchers. As previous Parkinson's conferences we aspire to make Parkinson's congress 2019 a grand success with the support of highly eminent speakers from Neuroscience and Parkinson’s disease communities. We promise our speakers world class hotel facilities and hospitality along with updated research knowledge on Parkinson’s and other neurological disorders.

According to World Health Organization (WHO) and World Federation of Neurology survey 6.3 million people are suffering with Parkinson's disease. The age is usually over 60 but it is estimated that one in tem are diagnosed before the age of 50 and it can affect people in their 40’s and younger Especially in Europe Parkinson’s disease is diagnosed 1 per 1000 people making it second most common neurodegenerative disorder.

As per the Neurological research till date with was clear that dopamine a neurotransmitter in brain gradually fall its level. Which leads to Parkinson’s disease it was observed that dopamine – generating cells known as dopaminergic neurons in the substantia nigra part of brain have died. Research say a male has 50% higher risk of developing Parkinson’s disease than a female, This progressive nervous system disorder affects the persons movement like speak, write and other voluntary movements different treatments for Parkinson’s disease were used but still death rate of Parkinson’s disease was gradually increasing. Approximately one million adults in USA are living with Parkinson’s disease and 60000 are diagnosed yearly and In United Kingdom 127000 people have Parkinson’s disease.